Tenax Therapeutics, Inc. · NASDAQ:TENX
Integrated Core Strategies (US) LLC reported a 5.60% stake in Tenax Therapeutics, Inc. (Schedule 13G)
Event Jun 26, 2025 · Filed Jun 30, 2025
Integrated Core Strategies (US) LLC reported a 5.60% stake in Tenax Therapeutics, Inc., 233,594 shares, as a passive investor on Jun 26, 2025. Filed Jun 30, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 233,594
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 5.60% | 233,594 |
| Millennium Management LLC | 5.60% | 233,616 |
| Millennium Group Management LLC | 5.60% | 233,616 |
| Israel A. Englander | 5.60% | 233,616 |
Source
Related
- Tenax Therapeutics, Inc.
- Millennium Management LLC
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · May 8, 2026
- Schedule 13G/A · Millennium Management LLC · Nov 5, 2025
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026